These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 26332906)
1. Spatial Distribution of Trehalose Dihydrate Crystallization in Tablets by X-ray Diffractometry. Thakral NK; Yamada H; Stephenson GA; Suryanarayanan R Mol Pharm; 2015 Oct; 12(10):3766-75. PubMed ID: 26332906 [TBL] [Abstract][Full Text] [Related]
2. Compression-induced crystallization of amorphous indomethacin in tablets: characterization of spatial heterogeneity by two-dimensional X-ray diffractometry. Thakral NK; Mohapatra S; Stephenson GA; Suryanarayanan R Mol Pharm; 2015 Jan; 12(1):253-63. PubMed ID: 25438193 [TBL] [Abstract][Full Text] [Related]
3. Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets. Debnath S; Predecki P; Suryanarayanan R Pharm Res; 2004 Jan; 21(1):149-59. PubMed ID: 14984270 [TBL] [Abstract][Full Text] [Related]
4. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction. Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047 [TBL] [Abstract][Full Text] [Related]
5. Monitoring phase transformations in intact tablets of trehalose by FT-Raman spectroscopy. Chakravarty P; Bhardwaj SP; King L; Suryanarayanan R AAPS PharmSciTech; 2009; 10(4):1420-6. PubMed ID: 19937407 [TBL] [Abstract][Full Text] [Related]
6. Calculation of the penetration depth of X-rays in intact pharmaceutical film-coated tablets by microdiffractometry. Yamada H; Suryanarayanan R Pharm Res; 2006 Sep; 23(9):2149-57. PubMed ID: 16906453 [TBL] [Abstract][Full Text] [Related]
7. Estimation of Drug Particle Size in Intact Tablets by 2-Dimensional X-Ray Diffractometry. Thakral S; Thakral NK; Suryanarayanan R J Pharm Sci; 2018 Jan; 107(1):231-238. PubMed ID: 28899809 [TBL] [Abstract][Full Text] [Related]
8. Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry. Koranne S; Govindarajan R; Suryanarayanan R Mol Pharm; 2017 Apr; 14(4):1133-1144. PubMed ID: 28195490 [TBL] [Abstract][Full Text] [Related]
9. Studies of the crystallization of amorphous trehalose using simultaneous gravimetric vapor sorption/near IR (GVS/NIR) and "modulated" GVS/NIR. Moran A; Buckton G AAPS PharmSciTech; 2009; 10(1):297-302. PubMed ID: 19296226 [TBL] [Abstract][Full Text] [Related]
10. Structural evolution of the dihydrate to anhydrate crystalline transition of trehalose as measured by wide-angle X-ray scattering. Kilburn D; Sokol PE J Phys Chem B; 2009 Feb; 113(7):2201-6. PubMed ID: 19166278 [TBL] [Abstract][Full Text] [Related]
11. Structure in dehydrated trehalose dihydrate--evaluation of the concept of partial crystallinity. Rani M; Govindarajan R; Surana R; Suryanarayanan R Pharm Res; 2006 Oct; 23(10):2356-67. PubMed ID: 16927180 [TBL] [Abstract][Full Text] [Related]
12. [Investigation of the recrystallization of trehalose as a good glass-former excipient]. Katona G; Orsolya JL; Szabóné RP Acta Pharm Hung; 2014; 84(1):7-14. PubMed ID: 24809162 [TBL] [Abstract][Full Text] [Related]
13. An anhydrous polymorphic form of trehalose. Nagase H; Endo T; Ueda H; Nakagaki M Carbohydr Res; 2002 Feb; 337(2):167-73. PubMed ID: 11814449 [TBL] [Abstract][Full Text] [Related]
14. Crystallization of trehalose in frozen solutions and its phase behavior during drying. Sundaramurthi P; Patapoff TW; Suryanarayanan R Pharm Res; 2010 Nov; 27(11):2374-83. PubMed ID: 20811935 [TBL] [Abstract][Full Text] [Related]
15. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets. Yamada H; Masuda K; Ishige T; Fujii K; Uekusa H; Miura K; Yonemochi E; Terada K J Pharm Biomed Anal; 2011 Sep; 56(2):448-53. PubMed ID: 21703798 [TBL] [Abstract][Full Text] [Related]
16. Quantification, mechanism, and mitigation of active ingredient phase transformation in tablets. Thakral NK; Ragoonanan V; Suryanarayanan R Mol Pharm; 2013 Aug; 10(8):3128-36. PubMed ID: 23869937 [TBL] [Abstract][Full Text] [Related]
17. Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction. Koivisto M; Heinänen P; Tanninen VP; Lehto VP Pharm Res; 2006 Apr; 23(4):813-20. PubMed ID: 16463008 [TBL] [Abstract][Full Text] [Related]
18. Molecular mobility as an effective predictor of the physical stability of amorphous trehalose. Bhardwaj SP; Suryanarayanan R Mol Pharm; 2012 Nov; 9(11):3209-17. PubMed ID: 23003337 [TBL] [Abstract][Full Text] [Related]
19. Estimation of crystallinity of trehalose dihydrate microspheres by usage of terahertz time-domain spectroscopy. Takeuchi I; Tomoda K; Nakajima T; Terada H; Kuroda H; Makino K J Pharm Sci; 2012 Sep; 101(9):3465-72. PubMed ID: 22499332 [TBL] [Abstract][Full Text] [Related]
20. Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase. Eriksson HJ; Hinrichs WL; van Veen B; Somsen GW; de Jong GJ; Frijlink HW Int J Pharm; 2002 Dec; 249(1-2):59-70. PubMed ID: 12433434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]